SCHEMBL25416405

SCHEMBL25416405

COCCn1cc(-c2cc(N)ncn2)cn1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FEN1 P39748 1/20 0.50
▸ JAK3 P52333 10/20 0.45
▸ JAK1 P23458 7/20 0.45
▸ JAK2 O60674 9/20 0.44
▸ IKBKE Q14164 4/20 0.44
▸ TBK1 Q9UHD2 4/20 0.44
▸ TYK2 P29597 2/20 0.44
▸ SYK P43405 1/20 0.43
▸ PIK3CD O00329 1/20 0.42
▸ PIK3CA P42336 1/20 0.42
▸ PIK3CG P48736 1/20 0.42
▸ LRRK2 Q5S007 1/20 0.42
▸ FGFR1 P11362 1/20 0.41
▸ FGFR2 P21802 1/20 0.41
▸ FGFR4 P22455 1/20 0.41
▸ FGFR3 P22607 1/20 0.41
▸ KDR P35968 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30373746 1.00 FEN1 (0.50) FEN1JAK3JAK1JAK2IKBKE
SCHEMBL22838439 0.76 ASIC3 (0.49) FEN1LRRK2FGFR3KDR
SCHEMBL31024131 0.76 ASIC3 (0.49) FEN1LRRK2FGFR3KDR
SCHEMBL31024037 0.75 DYRK1A (0.47) FEN1JAK3JAK1JAK2IKBKE
SCHEMBL25417862 0.75 DYRK1A (0.47) FEN1JAK3JAK1JAK2IKBKE
SCHEMBL14321130 0.73 FEN1 (0.49) FEN1JAK2IKBKETBK1PIK3CD
SCHEMBL30063989 0.72 ROCK2 (0.39) FEN1PIK3CDPIK3CAPIK3CG
SCHEMBL15885689 0.71 MET (0.45) FEN1IKBKETBK1SYKPIK3CD
SCHEMBL21425565 0.71 CSF1R (0.53) KDR
SCHEMBL1663037 0.71 MEN1 (0.45) FEN1JAK2IKBKETBK1PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4430047-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF Progentos Therapeutics, Inc. (US) 2024-09-18 — — EP disclosed
WO-2023081923-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF Frequency Therapeutics, Inc. (US) 2023-05-11 — — WO disclosed
WO-2023081923-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF Frequency Therapeutics, Inc. (US) 2023-05-11 — — WO disclosed
Send feedback